As a biomarker, the association between sLOX-1 and early atherosclerosis is not strong enough to be diagnostic in isolation, but these results warrant further research into the incorporation of sLOX-1 into biomarker panels, which many enable the precision diagnosis of atherosclerosis while it is still early enough to implement preventative strategies that can prevent heart attacks. Here, OLR1 is linked to atherosclerosis.